Form 4: MaxCyte Director Rekha Hemrajani Receives Stock Options and Restricted Stock Units

Director Rekha Hemrajani of MaxCyte, Inc. receives stock options and restricted stock units as part of the company's Equity Grant Policy for non-employee directors.

Summary

• Rekha Hemrajani, a director at MaxCyte, Inc., reported changes in beneficial ownership of securities.
• On June 11, 2024, Hemrajani acquired 21,367 shares of common stock in the form of restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of MaxCyte's common stock.
• Hemrajani also acquired stock options for 40,701 shares of common stock with an exercise price of $4.68.
• The stock options were granted on June 11, 2024, and expire on June 10, 2034.
• The shares underlying the RSU grant vest on June 11, 2025, contingent upon Hemrajani's continued service as a director.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard compensation practices and aligns director interests with shareholders.

Positives

• The equity grants align the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

Equity grants to directors are a common practice to incentivize and align their interests with the company's long-term performance. This is standard compensation for board members in publicly traded companies.

Comparison to Industry Standards

• Equity grants to non-employee directors are a common practice across the biotechnology industry.
• Companies like CRISPR Therapeutics and Editas Medicine also utilize stock options and restricted stock units as part of their director compensation packages.
• The size of the grant is typical for a company of MaxCyte's size and market capitalization.

Stakeholder Impact

• The equity grants align the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
• Employees may view the grants as a positive sign of the company's commitment to its leadership.

Key Dates